Wufsus, A., Delicou, S., El Rassi, F., Andemariam, B., Abboud, M. R., Kanter, J., Telen, M. J., Githanga, J., Inati, A., Idris, I. M., Navani, S., Wu, E., & Eisenberger, A. (2025). Etavopivat Reduces Incidence of Vaso-occlusive Crises in Patients With Sickle Cell Disease: Hibiscus Trial Phase 2 Results through 52 Weeks. Journal of Sickle Cell Disease, 2(Supplement_1). https://doi.org/10.1093/jscdis/yoaf013.002